| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.22 | 0.06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |